[Federal Register Volume 89, Number 93 (Monday, May 13, 2024)]
[Notices]
[Pages 41441-41442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10358]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-23HS]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``National Survey of Syringe Services 
Programs (NSSSP)'', to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
May 4, 2023, to obtain comments from the public and affected agencies. 
CDC received two public comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Program Evaluation for PS22-2208 Component 2--New--National Center 
for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for 
Disease Control and Prevention, Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    PS22-2208 Component 2 (Strengthening Syringe Services Programs) 
serves as a coordinated and accountable mechanism for distribution of 
funding to syringe services programs (SSPs) to support implementation 
and expansion of services in areas of the United States, Territories, 
and Tribal Nations disproportionately affected by infectious disease 
consequences of injection drug use. Project activities will directly 
contribute to establishing and expanding a national SSP infrastructure 
and prevention of infectious disease consequences of drug use. CDC has 
funded the National Alliance of State and Territorial AIDs Directors 
(NASTAD) to implement this project. NASTAD, in partnership with 
University of Washington will collect monitoring and evaluation data 
from funded SSPs through their internal mechanisms, both for their 
internal evaluation as well as to report semi-annual and annual project 
performance reports and stratified aggregate data to CDC. The primary 
purpose of this information collection is to monitor and evaluate the 
PS22-2208 Component 2 funding opportunity's overall goal of supporting 
SSP subrecipients in meeting the needs of people who use drugs (PWUD) 
and reducing infectious disease and other harms related to drug use.
    During the first year of this Cooperative Agreement, all PS22-2208 
SSP subrecipients will be sent a 25-minute baseline program evaluation 
survey at the start of project implementation, and a 15-minute 
quarterly program evaluation survey in the following three quarters of 
the project period. For Years 2-5, new PS22-2208 SSP subrecipients will 
be sent the baseline survey at the start of project implementation, and 
all existing subrecipients will receive the quarterly program 
evaluation survey in the following three quarters of the project 
period. SSP subrecipients will primarily complete the survey online in 
REDCap, with options to complete via telephone or videoconferencing 
modalities. Subrecipients will be asked to complete the surveys within 
one month of receipt and will receive weekly reminders until the survey 
is complete. SSP subrecipients may be reminded informally during 
meetings with NASTAD and may also work with their NASTAD point-of-
contact to determine an alternate method of survey completion. The 
survey will include questions on operational and programmatic 
characteristics, and quantity of prevention and treatment services 
provided in-person, through tele-health, and through navigation to off-
site care, during the specified evaluation period.
    Approximately 200 SSPs will participate in the survey. We estimate 
that it will take 70 minutes for each SSP

[[Page 41442]]

to complete the baseline survey and three quarterly surveys, regardless 
of how the respondent chooses to complete it (i.e., self-administered 
online or NASTAD staff-administered by phone or videoconferencing). CDC 
requests OMB approval for an estimated 233 annual burden hours. There 
is no cost to survey participants other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
              Respondent                          Form               Number of     responses per   per response
                                                                    respondents     respondent        (hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs................  Strengthening Syringe                200               1           25/60
                                         Services Programs
                                         Baseline Survey.
All participating SSPs................  Strengthening Syringe                200               3           15/60
                                         Services Programs
                                         Quarterly Survey.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-10358 Filed 5-10-24; 8:45 am]
BILLING CODE 4163-18-P